Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors

por Peacock, Jacqueline D, Cherba, David, Kampfschulte, Kevin, Smith, Mallory K, Monks, Noel R, Webb, Craig P, Steensma, Matthew
Publicado 2013

Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling

por Foley, Jessica M, Scholten II, Donald J, Monks, Noel R, Cherba, David, Monsma, David J, Davidson, Paula, Dylewski, Dawna, Dykema, Karl, Winn, Mary E, Steensma, Matthew R
Publicado 2015

A multi-site feasibility study for personalized medicine in canines with Osteosarcoma

por Monks, Noel R, Cherba, David M, Kamerling, Steven G, Simpson, Heather, Rusk, Anthony W, Carter, Derrick, Eugster, Emily, Mooney, Marie, Sigler, Robert, Steensma, Matthew, Grabinski, Tessa, Marotti, Keith R, Webb, Craig P
Publicado 2013

Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue

por Monsma, David J, Monks, Noel R, Cherba, David M, Dylewski, Dawna, Eugster, Emily, Jahn, Hailey, Srikanth, Sujata, Scott, Stephanie B, Richardson, Patrick J, Everts, Robin E, Ishkin, Aleksandr, Nikolsky, Yuri, Resau, James H, Sigler, Robert, Nickoloff, Brian J, Webb, Craig P
Publicado 2012

Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors

por Sale, Matthew J., Minihane, Emma, Monks, Noel R., Gilley, Rebecca, Richards, Frances M., Schifferli, Kevin P., Andersen, Courtney L., Davies, Emma J., Vicente, Mario Aladren, Ozono, Eiko, Markovets, Aleksandra, Dry, Jonathan R., Drew, Lisa, Flemington, Vikki, Proia, Theresa, Jodrell, Duncan I., Smith, Paul D., Cook, Simon J.
Publicado 2019